14 Apr 2021

Bone Grafts & Substitutes market expected CAGR is 5.8% during (2020-2030)


Related Report : Bone Grafts and Substitutes Market - by Product (Allografts {Machined Allografts and Demineralized Bone Matrix}, Bone Graft Substitutes {Morphogenic Proteins (BMP) and Synthetic Bone Grafts}, and Cell-Based Matrices), by Applications (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting), by End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers, and Others), and By Region- Global Opportunity Analysis and Industry Forecast, 2020 - 2030

Bone Grafts & Substitutes market expected CAGR is 5.8% during (2020-2030)

 

Bone grafts are implantable materials, which promote bone healing, bone formation, and osseous reconstruction owing to their Osteoinductive, Osteoconductive, and osseous formation properties. Also, they can be used to fill voids in absence of bones or help in provisional structural stability. Bone Grafts & substitutes find its application in sports, trauma, facial, and spinal surgery.

Bone Grafts & Substitutes market is poised to grow at a CAGR of 5.8% during the forecast period of (2020-2030)

The global bone grafts & substitute market is expected to witness a CAGR of around 5.8% from 2020-2030 as per a new report published by Decision Foresight.

According to the report, a rise in the number of spinal fusion surgeries will fuel the demand for the market. According to the CDC, around 32% of the adult population and 60% of the elderly population are affected by spinal deformities as of 2017. There were around 488,000 spinal procedures performed in the US. The common cause of spinal fusion injury is trauma, falls, collisions or road accidents. Thus, rise in spinal fusion will drive the demand for bone grafts and substitutes.

Shift towards adoption of minimally invasive surgeries (MIS) over traditional open surgeries is further increasing the demand for bone grafts & substitutes market. Surgeons are inclined to opt for MIS rather traditional open surgeries. As per Minim Invasive Surg, in 2018, minimally invasive techniques are being adopted for treatment of a wide range of bone disorders. Approximately 400,000 spinal fusion procedures are performed in the US annually and it has turned to be one of the most treated and well-established treatment options for spine trauma, degenerative disorders, tumors, and structural abnormalities

In 2019, the allograft segment is expected to hold the largest share of the bone grafts and substitute market. Rising preference of allograft over autograft is driving the growth of this segment. This is attributed to the unique characteristics such as immediate structural support and osteoconductivity. Also, use of allograft do not require another surgery to harvest bone, this results in reduced surgery time and fasterrecovery. Hence, allografts are most commonly used in spinal fusion, hip and knee replacement.

On the other hand, synthetic bone graft segment is expected to witness higher growth rate during the study time frame. The high growth of this product segment is attributed to improved biocompatibility, low risk of disease transmission, shorter duration of surgery, minimal blood loss and reduced pain, and better acceptance among the patients over allograft. Despite the positive attributes, a stringent regulatory guideline in some countries limits the growth of this product segment.

Dental bone grafting is the fastest growing application segment in 2019. The use of grafts in the field of dentistry is expected to open new avenues for the market players. The grafts are used as scaffold and filler to facilitate bone formation and promote healing. Growth in dental implant procedures with advanced surgical techniques such as bone grafts and bone regeneration further escalates the market. Also factors such as significant government expenditure on dental services, and favorable reimbursement scenario further support the growth of this application segment.

To strengthen their presence in the global bone grafts and substitutes market, industry leaders are aiming to receive regulatory approvals. Apart from this player also focuses on mergers & acquisitions, partnership, collaborations, agreements to widen their reach. Prominent players operating in this market are Medtronic plc, Stryker, Depuy Synthes (a Johnson & Johnson Company), AlloSource, Integra Life Sciences, Baxter Healthcare, Stryker, Zimmer Biomet, Xtant Medical, NuVasive.Inc, and Wright Medical Group

Browse key insights, market data & figures from the report, “Bone Grafts & Substitute Market Size By Type (Allograft, Bone Graft Substitutes, and Cell-Based Matrices), By Application (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting) and By Region (US, Canada, Mexico, Germany, UK, France, Japan, China, India, and Rest of the World), Growth potential, Price Trends, Competitive Market Share & Forecast, 2020-2030”

Market Segmentation

This research report categorizes the global bone grafts & substitutes market by type, application, and region

By Type

  • Allograft
  • Machined Allograft
  • Demineralized bone matrix
  • Bone Graft Substitute
  • Bone Morphogenic Proteins (BMP)
  • Synthetic Bone Grafts
  • Cell-Based Matrices

By Application

  • Spinal Fusion
  • Trauma
  • Joint Reconstruction
  • Dental Bone Grafting
  • Craniomaxillofacial

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World (Row)
  • Brazil
  • Israel
  • Saudi Arabia
  • South Africa
  • Others

 

©2024 Decision Foresight. All Rights Reserved.